Variant report
Variant | nsv467667 |
---|---|
Chromosome Location | chr11:5091633-5121790 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:91)
- CpG islands (count:0)
- Chromatin interactive region (count:18)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr11:5108595-5108795 | K562 | blood: | n/a | n/a |
2 | ATF1 | chr11:5108569-5108812 | K562 | blood: | n/a | n/a |
3 | BHLHE40 | chr11:5114577-5114619 | K562 | blood: | n/a | n/a |
4 | CCNT2 | chr11:5108478-5108879 | K562 | blood: | n/a | n/a |
5 | CEBPB | chr11:5112783-5113015 | A549 | lung: | n/a | chr11:5112874-5112883 chr11:5112873-5112884 chr11:5112872-5112883 |
6 | CEBPB | chr11:5112740-5112973 | K562 | blood: | n/a | chr11:5112874-5112883 chr11:5112873-5112884 chr11:5112872-5112883 |
7 | CEBPB | chr11:5108761-5108784 | K562 | blood: | n/a | n/a |
8 | CEBPB | chr11:5112719-5113020 | HepG2 | liver: | n/a | chr11:5112874-5112883 chr11:5112873-5112884 chr11:5112872-5112883 |
9 | CEBPB | chr11:5106216-5106419 | K562 | blood: | n/a | chr11:5106344-5106357 chr11:5106344-5106357 chr11:5106346-5106357 chr11:5106344-5106357 |
10 | CEBPB | chr11:5109257-5109343 | K562 | blood: | n/a | n/a |
11 | CEBPB | chr11:5110956-5111233 | IMR90 | lung: | n/a | chr11:5111080-5111091 chr11:5111078-5111091 chr11:5111080-5111089 |
12 | CEBPB | chr11:5111014-5111221 | K562 | blood: | n/a | chr11:5111080-5111091 chr11:5111078-5111091 chr11:5111080-5111089 |
13 | CEBPD | chr11:5108440-5108953 | K562 | blood: | n/a | n/a |
14 | CEBPD | chr11:5108435-5108905 | K562 | blood: | n/a | n/a |
15 | CTCF | chr11:5093220-5093370 | RPTEC | kidney: | n/a | n/a |
16 | CTCF | chr11:5120484-5120533 | ProgFib | skin: | n/a | n/a |
17 | CTCF | chr11:5121720-5121870 | Caco-2 | colon: | n/a | n/a |
18 | CTCF | chr11:5093200-5093350 | RPTEC | kidney: | n/a | n/a |
19 | CTCF | chr11:5093160-5093310 | HMEC | breast: | n/a | n/a |
20 | CTCF | chr11:5107528-5107600 | Fibrobl | skin: | n/a | n/a |
21 | ELK1 | chr11:5114428-5114497 | Hela-S3 | cervix: | n/a | n/a |
22 | EP300 | chr11:5092591-5092600 | GM12878 | blood: | n/a | n/a |
23 | EP300 | chr11:5108582-5108791 | K562 | blood: | n/a | n/a |
24 | FOS | chr11:5114569-5114719 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | FOS | chr11:5098941-5099205 | MCF10A-Er-Src | breast: | n/a | n/a |
26 | FOS | chr11:5114519-5114803 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | GATA2 | chr11:5112375-5112630 | K562 | blood: | n/a | n/a |
28 | IRF3 | chr11:5106714-5106752 | GM12878 | blood: | n/a | n/a |
29 | JUN | chr11:5117456-5117661 | HepG2 | liver: | n/a | chr11:5117562-5117575 chr11:5117588-5117602 |
30 | JUND | chr11:5108603-5108805 | K562 | blood: | n/a | n/a |
31 | JUND | chr11:5117450-5117681 | HepG2 | liver: | n/a | chr11:5117588-5117602 |
32 | MAFF | chr11:5117312-5117602 | K562 | blood: | n/a | n/a |
33 | MAFF | chr11:5102810-5102884 | HepG2 | liver: | n/a | n/a |
34 | MAFF | chr11:5104858-5105176 | K562 | blood: | n/a | chr11:5105024-5105042 |
35 | MAFF | chr11:5117282-5117578 | HepG2 | liver: | n/a | n/a |
36 | MAFF | chr11:5108789-5108913 | K562 | blood: | n/a | n/a |
37 | MAFF | chr11:5104862-5105212 | HepG2 | liver: | n/a | chr11:5105024-5105042 |
38 | MAFK | chr11:5102703-5102978 | IMR90 | lung: | n/a | n/a |
39 | MAFK | chr11:5114401-5114423 | Hela-S3 | cervix: | n/a | n/a |
40 | MAFK | chr11:5104858-5105186 | IMR90 | lung: | n/a | chr11:5105029-5105040 chr11:5105030-5105041 chr11:5105025-5105040 chr11:5105030-5105041 chr11:5105029-5105040 chr11:5105025-5105041 chr11:5105028-5105042 |
41 | MAFK | chr11:5102724-5102961 | HepG2 | liver: | n/a | n/a |
42 | MAFK | chr11:5117284-5117614 | HepG2 | liver: | n/a | chr11:5117409-5117423 |
43 | MAFK | chr11:5109753-5110002 | HepG2 | liver: | n/a | n/a |
44 | MAFK | chr11:5104917-5105117 | H1-hESC | embryonic stem cell: | n/a | chr11:5105029-5105040 chr11:5105030-5105041 chr11:5105025-5105040 chr11:5105030-5105041 chr11:5105029-5105040 chr11:5105025-5105041 chr11:5105028-5105042 |
45 | MAFK | chr11:5102763-5102986 | HepG2 | liver: | n/a | n/a |
46 | MAFK | chr11:5117290-5117587 | IMR90 | lung: | n/a | chr11:5117409-5117423 |
47 | MAFK | chr11:5117321-5117579 | HepG2 | liver: | n/a | chr11:5117409-5117423 |
48 | MAFK | chr11:5104881-5105189 | K562 | blood: | n/a | chr11:5105029-5105040 chr11:5105030-5105041 chr11:5105025-5105040 chr11:5105030-5105041 chr11:5105029-5105040 chr11:5105025-5105041 chr11:5105028-5105042 |
49 | MAFK | chr11:5104859-5105144 | Hela-S3 | cervix: | n/a | chr11:5105029-5105040 chr11:5105030-5105041 chr11:5105025-5105040 chr11:5105030-5105041 chr11:5105029-5105040 chr11:5105025-5105041 chr11:5105028-5105042 |
50 | MAFK | chr11:5104847-5105228 | HepG2 | liver: | n/a | chr11:5105029-5105040 chr11:5105030-5105041 chr11:5105025-5105040 chr11:5105030-5105041 chr11:5105029-5105040 chr11:5105025-5105041 chr11:5105028-5105042 |
No data |
(count:18 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:4918642..4921294-chr11:5101983..5104188,2 | K562 | blood: | |
2 | 11:5119128-5121895..11:5721056-5732713 | K562 | blood: | |
3 | 11:5102660-5106360..11:5469844-5475173 | H1-hESC | embryonic stem cell: | embryo |
4 | chr11:5058379..5061279-chr11:5093640..5097390,3 | K562 | blood: | |
5 | chr11:5107926..5109438-chr11:5115922..5117651,2 | K562 | blood: | |
6 | chr11:5104003..5106355-chr11:5107356..5109322,2 | K562 | blood: | |
7 | 11:5093737-5099374..11:5533869-5541626 | Hela-S3 | cervix: | |
8 | chr11:5104003..5106355-chr11:5107356..5109322,2 | K562 | blood: | |
9 | 11:5119128-5121895..11:5469844-5475173 | H1-hESC | embryonic stem cell: | embryo |
10 | chr11:5107926..5109438-chr11:5115922..5117651,2 | K562 | blood: | |
11 | 11:5102660-5106360..11:5250847-5268367 | Hela-S3 | cervix: | |
12 | chr11:5106264..5108013-chr11:5110270..5111995,2 | K562 | blood: | |
13 | 11:5093737-5099374..11:5250847-5268367 | Hela-S3 | cervix: | |
14 | chr11:5106264..5108013-chr11:5110270..5111995,2 | K562 | blood: | |
15 | 11:5119128-5121895..11:5250847-5268367 | H1-hESC | embryonic stem cell: | embryo |
16 | chr11:5117503..5120431-chr11:5123925..5125786,2 | K562 | blood: | |
17 | 11:5110510-5114921..11:5566274-5571131 | Hela-S3 | cervix: | |
18 | 11:5087036-5092291..11:5721056-5732713 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR52E3P | TF binding region |
OR52J1P | TF binding region |
OR52S1P | TF binding region |
ENSG00000203560 | chromatin interactions |
ENSG00000175518 | chromatin interactions |
ENSG00000132274 | chromatin interactions |
ENSG00000260629 | chromatin interactions |
ENSG00000229988 | chromatin interactions |
ENSG00000181616 | chromatin interactions |
ENSG00000223609 | chromatin interactions |
ENSG00000187918 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17352781 | chr11:5091633-5091634 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs544888561 | chr11:5091688-5091689 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs550492736 | chr11:5091702-5091703 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs545605505 | chr11:5091752-5091753 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs150588105 | chr11:5091753-5091754 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs546336944 | chr11:5091779-5091780 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs561452447 | chr11:5091840-5091841 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs369700862 | chr11:5091875-5091876 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs4144717 | chr11:5091882-5091883 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs191222599 | chr11:5091908-5091909 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs75873181 | chr11:5091918-5091919 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs78761083 | chr11:5091921-5091922 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs114700383 | chr11:5091935-5091936 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs533975778 | chr11:5091962-5091963 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs555559009 | chr11:5092004-5092005 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs574849481 | chr11:5092012-5092013 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs535917532 | chr11:5092050-5092051 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs557106543 | chr11:5092075-5092076 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs575582970 | chr11:5092077-5092078 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs2054140 | chr11:5092087-5092088 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs528998557 | chr11:5092199-5092200 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs564437752 | chr11:5092232-5092233 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs573154078 | chr11:5092243-5092244 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs540437792 | chr11:5092246-5092247 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs145847005 | chr11:5092291-5092292 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs182619322 | chr11:5092338-5092339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs186114786 | chr11:5092350-5092351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs565598557 | chr11:5092363-5092364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs201536657 | chr11:5092365-5092366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs5789361 | chr11:5092366-5092367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs397773958 | chr11:5092375-5092376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs192222542 | chr11:5092377-5092378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs116057554 | chr11:5092386-5092387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs377316362 | chr11:5092395-5092396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs6578549 | chr11:5092396-5092397 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs113132427 | chr11:5092400-5092401 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs536215943 | chr11:5092410-5092411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs566780980 | chr11:5092442-5092443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs76278555 | chr11:5092447-5092448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs549223617 | chr11:5092448-5092449 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs183498972 | chr11:5092456-5092457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs552378749 | chr11:5092462-5092463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs77306121 | chr11:5092540-5092541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs2959187 | chr11:5092560-5092561 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
45 | rs571452471 | chr11:5092596-5092597 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs576060984 | chr11:5092648-5092649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs16909667 | chr11:5092663-5092664 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs539450617 | chr11:5092672-5092673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs546726319 | chr11:5092717-5092718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs187977251 | chr11:5092730-5092731 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 19432969 | CNVD |
Alzheimer''s disease | 17576883 | CNVD |
Long-qt syndrome | 17576883 | CNVD |
Emphysema | 19352772 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 16608533 | CNVD |
Cancer | 21183584 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Neuroblastoma | 21124317 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Schizophrenia | 21399695 | CNVD |
Gastric cancer | 16891809 | CNVD |
Cancer | 17160897 | CNVD |
Multiple myeloma | 16616336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:5086200-5093000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr11:5092800-5093200 | Enhancers | Adipose Nuclei | Adipose |
3 | chr11:5093000-5093400 | Enhancers | H1 Cell Line | embryonic stem cell |
4 | chr11:5093000-5093400 | Enhancers | H9 Cell Line | embryonic stem cell |
5 | chr11:5093000-5093400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr11:5093200-5093600 | Flanking Active TSS | Adipose Nuclei | Adipose |
7 | chr11:5093600-5094200 | Enhancers | Adipose Nuclei | Adipose |
8 | chr11:5098000-5098200 | ZNF genes & repeats | Right Atrium | heart |
9 | chr11:5100200-5100800 | Enhancers | Liver | Liver |
10 | chr11:5108000-5108400 | Enhancers | K562 | blood |
11 | chr11:5108000-5108600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
12 | chr11:5108200-5108400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr11:5108400-5108800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
14 | chr11:5108400-5108800 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr11:5108400-5109000 | Flanking Active TSS | K562 | blood |
16 | chr11:5108400-5109200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
17 | chr11:5108600-5108800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
18 | chr11:5108800-5109600 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
19 | chr11:5108800-5110000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
20 | chr11:5109600-5110600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
21 | chr11:5110000-5110600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
22 | chr11:5110400-5110600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
23 | chr11:5113800-5114400 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
24 | chr11:5114000-5114800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
25 | chr11:5120600-5120800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
26 | chr11:5120800-5123400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |